Filing Details

Accession Number:
0000950170-23-048794
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-19 16:30:08
Reporting Period:
2023-09-15
Accepted Time:
2023-09-19 16:30:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1521036 Lantheus Holdings Inc. LNTH In Vitro & In Vivo Diagnostic Substances (2835) 352318913
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1861113 Daniel Niedzwiecki C/O Lantheus Holdings, Inc.
201 Burlington Road, South Bldg
Bedford MA 01730
See Remarks No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-09-15 2,846 $17.79 69,141 No 4 M Direct
Common Stock Disposition 2023-09-15 2,846 $66.43 66,295 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2023-09-15 2,846 $0.00 2,846 $17.79
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2023-11-06 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2023.
  2. The stock options under this grant vested in equal installments over a four-year period beginning on November 6, 2013.